Skip to main content
Log in

Analysis of Mutations of the RET Proto-oncogene in Patients with Medullary Thyroid Carcinoma

  • Published:
Russian Journal of Genetics Aims and scope Submit manuscript

Abstract

The spectrum of mutations of the RET proto-oncogene was analyzed in Russian patients with inherited or sporadic medullary thyroid carcinoma (MTC). Four RET exons (11, 13, 15, and 16) were subjected to molecular analysis, and mutations were revealed and identified in 47.4% (9/19) patients with sporadic MTC. In total, six different mutations (including three new ones) were observed. The most common mutation affected codon 918 to cause substitution of methionine with threonine and accounted for 31.6% alleles. Analysis of exons 11 and 16 revealed four types of mutations in patients with inherited multiple endocrine neoplasia type 2 (MEN 2). Mutations were found in each patient. Thyroidectomy was performed in four asymptomatic carriers of RET mutations from three MEN 2A families (in two families, affected relatives had bilateral pheochromocytoma). In two patients, analysis of the surgery material revealed MTC microfoci in both lobes of the thyroid gland. The results provide the ground for constructing a bank of genetic information on Russian MTC patients with the clinically verified diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schimke, R.N., Genetic Aspects of Multiple Endocrine Neoplasia, Annu. Rev. Med., 1984, vol. 35, pp. 25-31.

    Google Scholar 

  2. Gorlin, R.J., Sedano, H.O., Vickers, R.A., et al., Multiple Mucosal Neuromas, Pheochromocytoma and Medullary Carcinoma of the Thyroid—A Syndrome, Cancer, 1968, vol. 22, no. 2, pp. 293-299.

    Google Scholar 

  3. Farndon, J.R., Leight, G.S., Dilley, W.G., et al., Familial Medullary Thyroid Carcinoma without Associated Endocrinopathies: A Distinct Clinical Entity, Br. J. Surg., 1986, vol. 73, pp. 278-281.

    Google Scholar 

  4. Hofstra, R.M.W., Landsvater, R.M., Ceccherini, J., et al., A Mutation in the RET Proto-oncogene Associated with Multiple Endocrine Neoplasia Type 2B and Sporadic Medullary Thyroid Carcinoma, Nature, 1994, vol. 367, no. 6461, pp. 375-376.

    Google Scholar 

  5. Mulligan, L.M., Kwok, J.B., Healey, C.S., et al., Germ-Line Mutations of the RET Proto-oncogene in Multiple Endocrine Neoplasia Type 2A, Nature, 1993, vol. 363, no. 6428, pp. 458-460.

    Google Scholar 

  6. Amosenko, F.A., Kalinin, V.N., Kozlova, V.M., et al., Mutations of the RET Proto-oncogene in Patients with Medullary Thyroid Carcinoma and the Possibilities of Presymptomatic Diagnostics and Preventive Treatment of This Disorder, Vestn. Ross. Onkol. Nauchn. Tsentra im. N.N. Blokhina, 2000, no. 1, pp. 20-26.

    Google Scholar 

  7. Carlson, K.M., Dou, S., Chi, D., et al., Single Missense Mutation in the Tyrosine Kinase Catalytic Domain of the RET Proto-oncogene Is Associated with Multiple Endocrine Neoplasia Type 2B, Proc. Natl. Acad. Sci. USA, 1994, vol. 91, no. 4, pp. 1579-1583.

    Google Scholar 

  8. Rossel, M., Schuffenecker, I., Schlumberger, M., et al., Detection of a Germline Mutation at Codon 918 of the RET Proto-oncogene in French MEN 2B Families, Hum. Genet., 1995, vol. 95, no. 4, pp. 403-406.

    Google Scholar 

  9. Lips, C.J.M., Landsvater, R.M., Hoppener, J.W.M., et al., Clinical Screening as Compared with DNA Analysis in Families with Multiple Endocrine Neoplasia Type 2A, N. Engl. J. Med., 1994, vol. 331, pp. 828-835.

    Google Scholar 

  10. Schuffenecker, I., Billaud, M., Calender, A., et al., RET Proto-oncogene Mutations in French MEN 2A and FMTC Families, Hum. Mol. Genet., 1994, vol. 3, no. 11, pp. 1939-1943.

    Google Scholar 

  11. GenBank USA, accession no. AF082330-AF082337.

  12. Amosenko, F.A., Trubnikova, I.S., Zakharyev, V.M., et al., UB9 Polymorphism in the CFTR Gene of Cystic Fibrosis Patients, Carriers, and Healthy Donors from the Moscow Region: SSCP and Restriction Enzyme Analyses, Genetics, 1997, vol. 33, no. 2, pp. 198–202.

    Google Scholar 

  13. Eng, C., Smith, D.P., Mulligan, L.M., et al., Point Mutation within the Tyrosine Kinase Domain of the RET Proto-oncogene in Multiple Endocrine Neoplasia Type 2B and Related Sporadic Tumors, Hum. Mol. Genet., 1994, vol. 3, pp. 237-241.

    Google Scholar 

  14. Kalinin, V.N., Olek, K., Shmidt, V., et al., Allele-Specific Sequencing, Dokl. Akad. Nauk, 1995, vol. 343, no. 5, pp. 692-694.

    Google Scholar 

  15. Kalinin, V.N., Amosenko, F.A., Shabanov, M.A., et al., Three Novel Mutations in the RET Proto-oncogene as Somatic Mutations Associated with Medullary Thyroid Carcinoma, J. Mol. Med., 2001, vol. 79, no. 10, pp. 609-612.

    Google Scholar 

  16. Asai, N., Iwashita, T., Matsuyama, M., et al., Mechanism of Activation of the RET Proto-oncogene by Multiple Endocrine Neoplasia 2A Mutations, Mol. Cell. Biol., 1995, vol. 15, pp. 1613-1619.

    Google Scholar 

  17. Borrello, M.G., Smith, D.P., Pasini, B., et al., RET Activation by Germline MEN 2A and MEN 2B Mutations, Oncogene, 1995, vol. 11, pp. 2419-2427.

    Google Scholar 

  18. Santoro, M., Carlomagno, F., Romano, A., et al., Activation of RET as Dominant Transforming Gene by Germline Mutations of MEN 2A and MEN 2B, Science, 1995, vol. 267, no. 5196, pp. 381-383.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amosenko, F.A., Brzhezovskiy, V.Z., Lyubchenko, L.N. et al. Analysis of Mutations of the RET Proto-oncogene in Patients with Medullary Thyroid Carcinoma. Russian Journal of Genetics 39, 706–711 (2003). https://doi.org/10.1023/A:1024474314212

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024474314212

Keywords

Navigation